Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte®) In Adult Acute Lymphoblastic Leukemia (ALL)
Renato Bassan(Pittini Group (Italy)), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Orietta Spinelli(Ospedale Papa Giovanni XXIII), Andrea Gallamini(Centre Antoine Lacassagne), Elena Oldani(Ospedale Papa Giovanni XXIII), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Vincenzo Cassibba, Chiara Cattaneo(Humanitas University), Sergio Cortelazzo(Azienda Ospedaliero-Universitaria delle Marche), Arianna Masciulli(Ospedale Papa Giovanni XXIII), Consuelo Corti(IRCCS Ospedale San Raffaele), Claudio Romani(Azienda Ospedaliera G. Brotzu), Filippo Marmont(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Tamara Intermesoli(University of Bergamo), Agostino Cortelezzi(University of Milan), Margherita Parolini(Ospedale Papa Giovanni XXIII), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Monica Fumagalli(Azienda Ospedaliera San Gerardo), Enrico Maria Pogliani(Azienda Ospedaliera San Gerardo), Roberto Marchioli, Rosa Maria Marfisi(Mario Negri Sud Foundation), Daniele Mattei, Manuela Tosi(Ospedale Papa Giovanni XXIII), Anna Maria Scattolin(Ospedale dell' Angelo)
Cited by 2
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
|JAMA|2005|1.1k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627